⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28559478 | 0.94 | ALDH1A1 (0.53) | — | |
| SCHEMBL3224933 | 0.79 | SIGMAR1 (0.39) | — | |
| SCHEMBL272499 | 0.78 | SIGMAR1 (0.52) | — | |
| SCHEMBL7959398 | 0.77 | CFTR (0.48) | — | |
| SCHEMBL10198086 | 0.77 | MAT2A (0.45) | — | |
| SCHEMBL9988136 | 0.75 | SIGMAR1 (0.50) | — | |
| SCHEMBL9988138 | 0.75 | SIGMAR1 (0.50) | — | |
| SCHEMBL28554683 | 0.73 | ALDH1A1 (0.50) | — | |
| SCHEMBL41762 | 0.69 | — | — | |
| SCHEMBL7212942 | 0.69 | ALDH1A1 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11389464-B2 | Arginase inhibitors as therapeutics | MARS, INCORPORATED (US) | 2022-07-19 | — | — | US | disclosed |
| EP-3719024-A1 | ARGINASE INHIBITORS AS THERAPEUTICS | Mars, Incorporated (US) | 2020-10-07 | — | — | EP | disclosed |
| US-20200246362-A1 | Arginase Inhibitors as Therapeutics | MARS, INCORPORATED | 2020-08-06 | — | — | US | disclosed |
| CN-106008569-B9 | Borate as arginase inhibitor and composition and application thereof | 马尔斯公司 | 2020-05-22 | — | — | CN | disclosed |
| EP-3034509-B1 | ARGINASE INHIBITORS AS THERAPEUTICS | MARS INC (US) | 2020-04-22 | — | — | EP | disclosed |
| CN-106008569-B | Borate as arginase inhibitor and composition and application thereof | 马尔斯公司 | 2020-04-03 | — | — | CN | disclosed |
| US-10603330-B2 | Arginase inhibitors as therapeutics | MARS, INCORPORATED (US) | 2020-03-31 | — | — | US | disclosed |
| US-20190054101-A1 | ARGINASE INHIBITORS AS THERAPEUTICS | MARS, INCORPORATED | 2019-02-21 | — | — | US | disclosed |
| EP-2560978-B1 | INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS | MARS INC (US) | 2019-01-30 | — | — | EP | disclosed |
| US-20180296532-A1 | RNA-Focused Small Molecules for Inhibiting RNA Toxicity in Myotonic Dystrophy | SCRIPPS RESEARCH INST (US) | 2018-10-18 | — | — | US | disclosed |
| EP-2561754-A2 | CYCLOPROPENE COMPOUND, AND METHOD FOR ADDING SAME TO CROPS | Erum Biotechnologies Inc. (KR) | 2013-02-27 | — | — | EP | disclosed |
| US-20120322662-A1 | CYCLOPROPENES AND METHOD FOR APPLYING CYCLOPROPENES TO AGRICULTURAL PRODUCTS OR CROPS | ERUM BIOTECHNOLOGIES INC. (KR) | 2012-12-20 | — | — | US | disclosed |
| US-20120149708-A1 | MODULATORS OF VIRAL TRANSCRIPTION, AND METHODS AND COMPOSITIONS THEREWITH | GEORGE MASON UNIVERSITY | 2012-06-14 | — | — | US | disclosed |
| US-20120129806-A1 | ARGINASE INHIBITORS AS THERAPEUTICS | MARS, INCORPORATED | 2012-05-24 | — | — | US | disclosed |
| US-20120083469-A1 | INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS | MARS, INCORPORATED | 2012-04-05 | — | — | US | disclosed |
| WO-2011133653-A1 | INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS | MARS, INCORPORATED (US) | 2011-10-27 | — | — | WO | disclosed |
| WO-2010005384-A1 | KETONE PYRIDINE ANALOGUES AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS | ASTRAZENECA AB (SE) | 2010-01-14 | — | — | WO | disclosed |
| US-6767856-B1 | OLEFIN POLYMERIZATION CATALYST COMPRISING CATIONIC COMPLEX THAT RESULTS FROM CONTACT OF NEUTRAL TRANSITION METAL COMPOUND TO ACTIVATOR COMPOSITION | UNIVATION TECHNOLOGIES, LLC | 2004-07-27 | — | — | US | disclosed |
| EP-1311557-A1 | TRANSITION METAL OLEFIN POLYMERIZATION CATALYST HAVING CYCLOPROPENYL DERIVED LIGANDS | Univation Technologies LLC (US) | 2003-05-21 | — | — | EP | disclosed |
| WO-2002012351-A1 | TRANSITION METAL OLEFIN POLYMERIZATION CATALYST HAVING CYCLOPROPENYL DERIVED LIGANDS | UNIVATION TECHNOLOGIES, LLC (US) | 2002-02-14 | — | — | WO | disclosed |